UiPath (PATH) – Investment Analysts’ Recent Ratings Updates

by · The Cerbat Gem

UiPath (NYSE: PATH) has recently received a number of price target changes and ratings updates:

  • 12/10/2025 – UiPath had its price target raised by analysts at Royal Bank Of Canada from $16.00 to $19.00. They now have a “sector perform” rating on the stock.
  • 12/9/2025 – UiPath was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c)” rating.
  • 12/9/2025 – UiPath had its price target raised by analysts at Morgan Stanley from $15.00 to $19.00. They now have an “equal weight” rating on the stock.
  • 12/6/2025 – UiPath was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
  • 12/4/2025 – UiPath was given a new $17.00 price target on by analysts at Truist Financial Corporation.
  • 12/4/2025 – UiPath had its price target raised by analysts at BMO Capital Markets from $13.00 to $17.00. They now have a “market perform” rating on the stock.
  • 12/4/2025 – UiPath had its “neutral” rating reaffirmed by analysts at UBS Group AG.
  • 12/4/2025 – UiPath had its price target raised by analysts at Royal Bank Of Canada from $14.00 to $16.00. They now have a “sector perform” rating on the stock.
  • 12/4/2025 – UiPath had its “hold” rating reaffirmed by analysts at Cowen Inc.
  • 12/4/2025 – UiPath had its price target raised by analysts at DA Davidson from $12.00 to $15.00. They now have a “neutral” rating on the stock.
  • 12/4/2025 – UiPath had its price target raised by analysts at Evercore ISI from $15.00 to $17.00. They now have an “in-line” rating on the stock.
  • 12/4/2025 – UiPath had its price target raised by analysts at Mizuho from $14.00 to $15.00. They now have a “neutral” rating on the stock.
  • 12/4/2025 – UiPath had its price target raised by analysts at Canaccord Genuity Group Inc. from $15.00 to $19.00. They now have a “buy” rating on the stock.
  • 12/4/2025 – UiPath had its price target raised by analysts at Barclays PLC from $14.00 to $16.00. They now have an “equal weight” rating on the stock.
  • 12/4/2025 – UiPath had its price target raised by analysts at Wells Fargo & Company from $12.00 to $14.00. They now have an “equal weight” rating on the stock.
  • 12/4/2025 – UiPath had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
  • 11/15/2025 – UiPath was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
  • 11/4/2025 – UiPath was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
  • 10/30/2025 – UiPath had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
  • 10/25/2025 – UiPath was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
  • 10/23/2025 – UiPath was given a new $17.00 price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 10/23/2025 – UiPath was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating. They now have a $17.00 price target on the stock, up previously from $10.00.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $18.61, for a total transaction of $837,450.00. Following the completion of the transaction, the chief executive officer directly owned 29,063,585 shares of the company’s stock, valued at approximately $540,873,316.85. The trade was a 0.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Brad Brubaker sold 27,580 shares of the firm’s stock in a transaction that occurred on Friday, December 5th. The shares were sold at an average price of $18.55, for a total transaction of $511,609.00. Following the completion of the sale, the insider directly owned 635,359 shares in the company, valued at approximately $11,785,909.45. This trade represents a 4.16% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 2,391,582 shares of company stock worth $35,767,934. 23.19% of the stock is owned by corporate insiders.

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also